Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Price to Earnings (2019 - 2021)

Updated

Lexicon Pharmaceuticals' (LXRX) Price to Earnings stood at 17.41 in Q2 2021, up 219.2% from 5.46 a year earlier.

Analysis

Lexicon Pharmaceuticals (LXRX) Price to Earnings (2019 - 2021) Analysis & Trends

For FY2019, Lexicon Pharmaceuticals' Price to Earnings came in at 3.41.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 17.41
Jun 30, 2020 5.46
Mar 31, 2020 2.44
Dec 31, 2019 3.41
Sep 30, 2019 1.94
API Access

Lexicon Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=LXRX&period=max&api_key=YOUR_API_KEY